ABSTRACT
BACKGROUND: Foot pathologies can affect the kinetic chain during gait, leading to altered loading at other joints that can lead to subsequent pathologies. Although hallux valgus is the most common foot disease, little has been discussed about the biokinetic effects of hallux valgus on the foot and lower limb. This systematic review evaluated the kinematic, kinetic, and pedobarographic changes of the hallux valgus foot compared to a healthy one. METHODS: Several electronic databases were searched up to January 2022, including only cross-sectional studies with clearly defined isolated hallux valgus diseases and healthy groups. Two investigators independently rated studies for methodological quality using the NIH Study Quality Assessment Tool for cross-sectional studies. Kinetic data were extracted, including temporal data, kinematics of the foot joint, kinematics of the proximal lower limb, and pedobarography. We did meta-analyses tests with a random effects model using the metafor package in R. RESULTS: Hallux valgus patients walk slower compared to a disease-free control group -0.16 m/s (95% CI -0.27, -0.05). Hallux valgus patients exhibited significantly reduced coronal plane motion of the hindfoot-shank during preswing 1.16 degrees (95% CI 0.31, 2.00). Hallux valgus patients generated less force in the hallux region 33.48 N (95% CI 8.62, 58.35) but similar peak pressures in the hallux compared to controls. Hallux valgus patients generated less peak pressure at the medial and lateral hindfoot as compared to controls: 8.28 kPa (95% CI 2.92, 13.64) and 8.54 kPa (95% CI 3.55, 13.52), respectively. CONCLUSION: Although hallux valgus is a deformity of the forefoot, the kinematic changes due to the pathology are associated with significant changes in the range of motion at other joints, underscoring its importance in the kinetic chain. This is demonstrated again with the changes of peak pressure. Nevertheless, more high-quality studies are still needed to develop a fuller understanding of this pathology.
Subject(s)
Bunion , Hallux Valgus , Humans , Cross-Sectional Studies , Foot , Gait , Lower ExtremityABSTRACT
Background: Hallux valgus (HV) is a common cause of pain and deformity of the forefoot. Minimally invasive chevron Akin (MICA) bunionectomy is a method for HV correction associated with less pain and swelling, with early return to weightbearing in a regular shoe. The purpose of this study was to determine how the MICA procedure affects forefoot width. Methods: Twenty-eight patients (26 female, 2 male; 9 left, 19 right) at a single institution who underwent primary MICA for HV correction by 3 treating surgeons were retrospectively reviewed. Pre- and postoperative hallux valgus angle (HVA), intermetatarsal angle (IMA), distal metatarsal articular angle (DMAA), bony forefoot width, and soft tissue forefoot width were measured by 2 independent observers. Radiographic measurements were calibrated using fifth metatarsal length. Wilcoxon signed rank test compared changes in HVA, IMA, DMAA, and forefoot widths. Pearson correlation coefficient evaluated association between HVA, IMA, DMAA, and changes in forefoot width. Results: At mean follow-up of 5.4 (range 3-13.7) months, bony forefoot width decreased significantly by 3.7 mm (4%, P < .001) and soft tissue forefoot width decreased by 2.5 mm (2%, P < .01). Decrease in HVA was moderately correlated with change in bony forefoot width (r = .38, P < .05) and change in soft tissue forefoot width (r = .45, P < .05). Decrease in IMA was moderately correlated with change in bony forefoot width (r = .45, P < .05) and change in soft tissue forefoot width (r = .44, P < .05). Conclusion: The MICA procedure resulted in modest, yet significant, decrease in both bony and soft tissue forefoot width. Decrease in HVA and IMA demonstrated moderate correlation with changes in forefoot width. Patients can be counseled on these changes leading up to, and after, MICA bunionectomy surgery. Level of Evidence: Level III, retrospective comparative series.
ABSTRACT
OBJECTIVE: To evaluate the efficacy of platelet-rich plasma (PRP) and tranexamic acid (TXA) applied in total knee arthroplasty. METHODS: We selected and randomized 84 patients. TXA was applied in 23 patients, PRP in 20, and PRP in combination with TXA in 20. Hemoglobin was measured preoperatively and 24 and 48 hours postoperatively. The function questionnaire, pain scale and gain of knee flexion were monitored until the second postoperative year. RESULTS: There was a difference (p <0.01) in the decrease in hemoglobin 48 hours after surgery between the TXA group and the control and PRP groups. In terms of pain, the TXA group at 24 and 48 hours after surgery and the PRP group at 48 hours after surgery showed advantages (p <0.01). Knee flexion gain in the first 24 hours postoperatively was better in the TXA group (p <0.05). CONCLUSION: TXA was effective in lowering the drop in hemoglobin level, reducing pain and improving movement gain 48 hours after the procedure. PRP was not effective in reducing bleeding or improving knee function after arthroplasty, but provided better control of postoperative pain. Level of Evidence I, Randomized, blinded, prospective clinical trial.
OBJETIVO: Avaliar a eficácia do plasma rico em plaquetas (PRP) e do ácido tranexâmico (ATX) aplicados na artroplastia total do joelho. MÉTODOS: Selecionamos e randomizamos 84 pacientes. ATX foi aplicado em 23 pacientes, PRP em 20, e PRP associado a ATX em 20. A hemoglobina foi medida no pré-operatório e nas 24 e 48 horas após a cirurgia. O questionário de função, a escala de dor e o ganho de flexão do joelho foram verificados até o segundo ano de pós-operatório. RESULTADOS: Houve diferença(p < 0,01) na diminuição da hemoglobina 48 horas após a cirurgia entre o grupo ATX e os grupos controle e PRP. Na dor, o grupo ATX 24 e 48 horas após a cirurgia e o grupo PRP 48 horas após a cirurgia apresentaram vantagens (p < 0,01). O ganho de flexão do joelho nas primeiras 24 horas de pós-operatório foi melhor no grupo ATX (p < 0,05). CONCLUSÃO: O ATX foi eficaz na diminuição da queda da hemoglobina, reduzindo a dor e melhorando o ganho de movimento em 48 horas após o procedimento. O PRP não foi eficaz na redução do sangramento ou na melhora da função do joelho após a artroplastia, mas proporcionou melhor controle da dor pós-operatória. Nível de Evidência I, Randomizado, duplo cego, ensaio clínico prospectivo.
ABSTRACT
ABSTRACT Objective: To evaluate the efficacy of platelet-rich plasma (PRP) and tranexamic acid (TXA) applied in total knee arthroplasty. Methods: We selected and randomized 84 patients. TXA was applied in 23 patients, PRP in 20, and PRP in combination with TXA in 20. Hemoglobin was measured preoperatively and 24 and 48 hours postoperatively. The function questionnaire, pain scale and gain of knee flexion were monitored until the second postoperative year. Results: There was a difference (p <0.01) in the decrease in hemoglobin 48 hours after surgery between the TXA group and the control and PRP groups. In terms of pain, the TXA group at 24 and 48 hours after surgery and the PRP group at 48 hours after surgery showed advantages (p <0.01). Knee flexion gain in the first 24 hours postoperatively was better in the TXA group (p <0.05). Conclusion: TXA was effective in lowering the drop in hemoglobin level, reducing pain and improving movement gain 48 hours after the procedure. PRP was not effective in reducing bleeding or improving knee function after arthroplasty, but provided better control of postoperative pain. Level of Evidence I, Randomized, blinded, prospective clinical trial.
RESUMO Objetivo: Avaliar a eficácia do plasma rico em plaquetas (PRP) e do ácido tranexâmico (ATX) aplicados na artroplastia total do joelho. Métodos: Selecionamos e randomizamos 84 pacientes. ATX foi aplicado em 23 pacientes, PRP em 20, e PRP associado a ATX em 20. A hemoglobina foi medida no pré-operatório e nas 24 e 48 horas após a cirurgia. O questionário de função, a escala de dor e o ganho de flexão do joelho foram verificados até o segundo ano de pós-operatório. Resultados: Houve diferença(p < 0,01) na diminuição da hemoglobina 48 horas após a cirurgia entre o grupo ATX e os grupos controle e PRP. Na dor, o grupo ATX 24 e 48 horas após a cirurgia e o grupo PRP 48 horas após a cirurgia apresentaram vantagens (p < 0,01). O ganho de flexão do joelho nas primeiras 24 horas de pós-operatório foi melhor no grupo ATX (p < 0,05). Conclusão: O ATX foi eficaz na diminuição da queda da hemoglobina, reduzindo a dor e melhorando o ganho de movimento em 48 horas após o procedimento. O PRP não foi eficaz na redução do sangramento ou na melhora da função do joelho após a artroplastia, mas proporcionou melhor controle da dor pós-operatória. Nível de Evidência I, Randomizado, duplo cego, ensaio clínico prospectivo.
